Douglas E Williams's Net Worth
$12.6 Million
Who is Douglas E Williams?
Douglas E Williams has an estimated net worth of $12.6 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., Oncothyreon Inc., ZYMOGENETICS INC, Panacea Acquisition Corp. II, Ovid Therapeutics Inc., IRONWOOD PHARMACEUTICALS INC, Codiak BioSciences, Inc., Regulus Therapeutics Inc., ANADYS PHARMACEUTICALS INC, Sana Biotechnology, Inc., ARRAY BIOPHARMA INC, and SEATTLE GENETICS INC /WA.
SEC CIK
Douglas E Williams's CIK is 0001184847
Past Insider Trading and Trends
2009 was Douglas E Williams's most active year for acquiring shares with 9 total transactions. Douglas E Williams's most active month to acquire stocks was the month of January. 2015 was Douglas E Williams's most active year for disposing of shares, totalling 10 transactions. Douglas E Williams's most active month to dispose stocks was the month of January. 2018 saw Douglas E Williams paying a total of $32,441.50 for 27,036 shares, this is the most they've acquired in one year. In 2015 Douglas E Williams cashed out on 24,850 shares for a total of $3,993,627.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN INC. (BIIB) Snapshot price: $241.553
EVP Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.53% | -3.84K |
$410.00 | -$1,574,810.00 | 11.82K |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +21.30% | 2.75K |
$392.11 | -$960,669.50 | 15.66K |
Feb 12
| |||
Form 4
| +16.56% | 1.83K |
$402.00 | -$656,868.00 | 12.91K |
Feb 8
| |||
Form 4
| +38.84% | 3.1K |
$389.16 | -$801,280.44 | 11.07K |
Feb 1
| |||
Form 4
| -30.53% | -3.50K |
$352.29 | -$1,234,776.45 | 7.98K |
Scheduled
|
Mar 19
| ||
Form 4
| +19.68% | 1.89K |
$323.04 | -$544,322.40 | 11.48K |
Feb 12
| |||
Form 4
| +23.61% | 1.83K |
$315.54 | -$516,223.44 | 9.59K |
Feb 8
| |||
Form 4
| +69.79% | 3.19K |
$312.64 | -$615,588.16 | 7.76K |
Feb 1
| |||
Form 4
| -48.86% | -4.37K |
$211.35 | -$923,168.06 | 4.57K |
Scheduled
|
Aug 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +24.41% | 1.75K |
$164.44 | -$205,878.88 | 8.94K |
Feb 8
| |||
Form 4
| +93.93% | 3.48K |
$157.30 | -$264,106.70 | 7.18K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +869.23% | 3.5K |
$121.26 | -$200,806.56 | 3.91K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncothyreon Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -5.38% | -1.14K |
$1.86 | -$2,111.10 | 19.96K |
Jun 9
| |||
Form 4
| +63.26% | 8.17K |
$3.67 | $29,998.58 | 21.1K |
Jun 7
| |||
Form 4
| -25.15% | -4.34K |
$3.51 | -$7,093.71 | 12.92K |
Mar 16 - Jun 3
| |||
Form 4
| -8.22% | -1.55K |
$6.86 | -$10,605.56 | 17.26K |
Dec 4
| |||
Form 4
| +31.80% | 4.54K |
—
|
—
| 18.81K |
Jun 9
| |||
Form 4
| +130.74% | 8.09K |
—
|
—
| 14.27K |
Jun 3
| |||
Form 4
|
∞
| 6.18K |
—
|
—
| 6.18K |
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZYMOGENETICS INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.60K |
$9.75 | -$44,850.00 |
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
| +119.05% | 2.5K |
$8.99 | $22,475.00 | 4.6K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +5.00% | 100 |
—
|
—
| 2.1K |
Jan 17
| |||
Form 4
|
∞
| 2K |
$12.25 | $24,500.00 | 2K |
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Panacea Acquisition Corp. II No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ovid Therapeutics Inc. (OVID) Snapshot price: $3.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 5K |
$6.49 | $32,441.50 | 5K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||